[New directions in immunotherapy for malignant solid tumors].
Nihon Rinsho
; 70(12): 2075-86, 2012 Dec.
Article
in Ja
| MEDLINE
| ID: mdl-23259377
ABSTRACT
Despite advances in treatment modalities, malignant solid tumors remain devastating maladies. Conventional treatment with chemotherapy and radiation is still only partially effective and highly toxic. In the era of increasing knowledge of the molecular biology of tumors and the interaction between the tumor and immune system, the development of targeted agents, including cancer vaccines, has emerged as a promising modality. This article will summarize the recent progress in developing cancer vaccines and immunotherapeutic approaches including adoptive cell transfer and will further review currently ongoing phase II/III studies for malignant solid tumors in the world.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cancer Vaccines
/
Cell- and Tissue-Based Therapy
/
Immunotherapy
/
Neoplasms
Limits:
Humans
Language:
Ja
Journal:
Nihon Rinsho
Year:
2012
Document type:
Article